Silodosin glucuronide—the core glucose in drug metabolism research 879396-70-0

Silodosin Glucuronide is a key molecule in the field of drug metabolism and is the main metabolite of silodosin, a selective α1A-adrenergic receptor antagonist. In drug development and clinical research, glucuronidation metabolites are not only relevant to the evaluation of drug efficacy and safety, but also a core element in understanding drug clearance mechanisms and optimizing dosing regimens. This compound plays an indispensable role in pharmacokinetics, toxicology and precision medicine, providing an important bridge from basic research to clinical application.

Chemical Information

Chemical name: Silodosin Glucuronide

Common name: Silodosin glucuronide

Chemical formula: C31H40F3N3O10

Molecular weight: 671.67 g/mol

CAS number: 879396-70-0

Category: Metabolite Glucuronide

Structural features

Silodosin glucuronide is formed from the original drug silodosin through a glucuronidation reaction, and its structure has significant characteristics:

Glucuronic acid conjugation: A specific functional group (usually a hydroxyl or amino group) in the silodosin molecule is covalently linked to glucuronic acid through a beta-glycosidic bond. This modification greatly increases the polarity and water solubility of the molecule, promoting its dissolution and transport in body fluids.

Enhanced metabolic stability: Compared with the original drug, the glucuronide structure is usually more stable and can resist certain enzymatic hydrolysis processes, thereby extending the detection window of metabolites and facilitating experimental analysis.

Stereochemical specificity: Glucuronidation reactions, often catalyzed by uridine diphosphate glucuronosyltransferase (UGT), are regio- and stereoselective and produce metabolites with specific configurations, affecting their biological activity and excretion pathways.

Optimization of molecular interactions: The introduced glucuronic acid group can provide additional hydrogen bonding sites, which may change the binding mode with proteins or receptors, providing a structural basis for studying the function of metabolites.

Main applications and advantages

1. Precise tools for pharmacokinetic studies

In drug development, silodosin glucuronide is used as a standard reference material for quantitative analysis of metabolic levels in biological samples such as plasma and urine. Through technologies such as liquid chromatography-mass spectrometry, drug exposure, half-life and clearance can be accurately measured, providing data support for dose optimization and dosing frequency design. Its stable chemical properties ensure the reliability and reproducibility of experimental results and accelerate the process of preclinical and clinical trials.

2. Key indicators for toxicology and safety assessment

Glucuronidation is an important way for the body to detoxify and eliminate xenobiotics. The formation of silodosin glucuronide helps reduce the potential toxicity of the original drug and promotes renal excretion by increasing water solubility. Studying the accumulation and distribution of this metabolite can evaluate the impact of liver and kidney function on drug metabolism, identify metabolism-related adverse reactions (such as drug-induced liver injury or interaction risks), thereby improving drug safety files.

3. Exploration carrier for drug interactions and personalized medicine

Since the glucuronidation process is regulated by the UGT enzyme system, which is easily affected by genetic polymorphisms or concomitant drugs, silodosin glucuronide has become a powerful model for studying drug-drug interactions. By analyzing the changes in its production rate, the metabolic competition or inhibitory effects of combined drugs can be predicted and guide clinical medication adjustments. In addition, in personalized medicine, this metabolite level may be used as a phenotypic marker to reflect an individual's metabolic ability and help customize treatment plans.

4. Research platform on basic metabolic mechanisms and diagnostic potential

In basic science, silodosin glucuronide is used to explore the enzymatic mechanisms of glucuronidation, cellular transport processes (e.g., via the MRP2 transporter), and their changes in disease states. For example, in patients with renal insufficiency or hepatobiliary disease, abnormal metabolite kinetics may reveal pathophysiological clues, which may be developed into biomarkers for monitoring drug compliance or organ function in the future and promote innovation in diagnostic tools.

Conclusion

Silodosin glucuronide is far from a simple metabolic endpoint. It is an important molecule throughout the drug life cycle - from early discovery to clinical monitoring. Its value is reflected in deepening the understanding of metabolic pathways, improving the therapeutic safety window and promoting the development of precision medicine. With the advancement of analytical technology and the rise of metabolomics, the potential of this compound in the development of innovative therapies, disease management and translational research will continue to be unleashed, contributing key insights to medical science.

The above information is provided by the editor of KASONS and is for scientific research only.